Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arava in Systemic Lupus Erythematosus
NCT00637819Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leflunomide in systemic lupus erythematosus (SLE), sponsored by Sanofi. Started Jan 2003; status: completed.
02
Drugs
leflunomide
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00637819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00637819.